Form 4: Oscar Health Executive Sells Shares After Vesting of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


An Oscar Health executive, Alessandrea C. Quane, sold a portion of her Class A common stock after the vesting of restricted stock units, according to a recent SEC filing.

Summary

  • Alessandrea C. Quane, an EVP and Chief Insurance Officer at Oscar Health, Inc., engaged in multiple transactions involving Class A common stock.
  • On December 1, 2024, she acquired 7,015, 34,379, and 8,653 shares of Class A common stock through the vesting of restricted stock units.
  • On December 2, 2024, she sold 26,411 shares at a weighted average price of $18.07 and 484 shares at a weighted average price of $18.48.
  • These sales were executed to cover tax obligations related to the vesting of the restricted stock units.
  • Following these transactions, Ms. Quane directly owns 415,759 shares of Class A common stock and indirectly owns 76,857 shares through a 2024 GRAT.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction of stock sales by an executive to cover tax obligations. It is neither particularly positive nor negative.

Risks

  • Executive stock sales can sometimes be perceived negatively by the market, potentially impacting the stock price.
  • The sales were conducted to cover tax obligations, which is a common practice, but the volume of shares sold could be a concern for some investors.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies, and this filing is a routine disclosure of such activity. The sale of shares to cover tax obligations is a standard practice.

Comparison to Industry Standards

  • Executive stock sales are a common practice across the industry, particularly after the vesting of equity awards.
  • The use of Rule 10b5-1 plans for pre-planned sales is also a standard practice to avoid accusations of insider trading.
  • Companies like UnitedHealth Group (UNH) and Humana (HUM) also have executives who regularly file similar Form 4 documents related to stock transactions.

Stakeholder Impact

  • The stock sales may have a minor impact on the share price, but it is unlikely to be significant given the routine nature of the transaction.
  • The sales do not directly impact employees, customers, or suppliers.

Key Dates

DateDescription
12/01/2024Restricted stock units vested, resulting in the acquisition of Class A common stock.
12/02/2024Shares of Class A common stock were sold to cover tax obligations.
12/03/2024Date of the SEC filing.

Keywords

Oscar Health, stock sale, restricted stock units, insider trading, SEC Form 4, executive compensation, Class A common stock, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.